vs
Side-by-side financial comparison of Dianthus Therapeutics, Inc. (DNTH) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.
60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $284.0K, roughly 1.1× Dianthus Therapeutics, Inc.). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -22687.3%, a 22213.2% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -78.6%). 60 DEGREES PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-1.8M vs $-47.1M). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -44.6%).
Dianthus Therapeutics is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for rare immunological and inflammatory diseases. It advances antibody-based candidates to address unmet needs of severe patients, operating primarily in the U.S. with global development partners.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
DNTH vs SXTP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0K | $303.4K |
| Net Profit | $-64.4M | $-1.4M |
| Gross Margin | — | 60.2% |
| Operating Margin | -24486.3% | -632.0% |
| Net Margin | -22687.3% | -474.2% |
| Revenue YoY | -78.6% | 25.6% |
| Net Profit YoY | -126.6% | 29.7% |
| EPS (diluted) | $-1.53 | $-8.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0K | $303.4K | ||
| Q3 25 | $396.0K | $437.6K | ||
| Q2 25 | — | $100.9K | ||
| Q1 25 | $1.2M | $163.6K | ||
| Q4 24 | $1.3M | $241.6K | ||
| Q3 24 | $2.2M | $135.3K | ||
| Q2 24 | $1.9M | $125.0K | ||
| Q1 24 | $874.0K | $105.7K |
| Q4 25 | $-64.4M | $-1.4M | ||
| Q3 25 | $-36.8M | $-2.3M | ||
| Q2 25 | — | $-1.7M | ||
| Q1 25 | $-29.5M | $-1.9M | ||
| Q4 24 | $-28.4M | $-2.0M | ||
| Q3 24 | $-25.2M | $-2.2M | ||
| Q2 24 | $-17.6M | $-4.2M | ||
| Q1 24 | $-13.7M | $430.5K |
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | 50.4% | ||
| Q1 25 | — | 55.2% | ||
| Q4 24 | — | 51.1% | ||
| Q3 24 | — | 17.4% | ||
| Q2 24 | — | 28.3% | ||
| Q1 24 | — | 38.1% |
| Q4 25 | -24486.3% | -632.0% | ||
| Q3 25 | -10173.7% | -531.4% | ||
| Q2 25 | — | -1590.0% | ||
| Q1 25 | -2852.7% | -1168.4% | ||
| Q4 24 | -2406.9% | -854.7% | ||
| Q3 24 | -1376.6% | -1566.0% | ||
| Q2 24 | -1191.8% | -3351.8% | ||
| Q1 24 | -2041.6% | -1270.4% |
| Q4 25 | -22687.3% | -474.2% | ||
| Q3 25 | -9284.1% | -529.3% | ||
| Q2 25 | — | -1717.7% | ||
| Q1 25 | -2537.5% | -1147.4% | ||
| Q4 24 | -2144.8% | -846.3% | ||
| Q3 24 | -1159.0% | -1596.4% | ||
| Q2 24 | -945.1% | -3339.0% | ||
| Q1 24 | -1573.0% | 407.4% |
| Q4 25 | $-1.53 | $-8.26 | ||
| Q3 25 | $-0.97 | $-0.66 | ||
| Q2 25 | — | $-1.25 | ||
| Q1 25 | $-0.82 | $-1.56 | ||
| Q4 24 | $-0.76 | $-51.96 | ||
| Q3 24 | $-0.74 | $-2.92 | ||
| Q2 24 | $-0.51 | $-21.12 | ||
| Q1 24 | $-0.54 | $1.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $404.3M | $2.8M |
| Total DebtLower is stronger | — | $150.0K |
| Stockholders' EquityBook value | $493.4M | $3.5M |
| Total Assets | $530.9M | $5.4M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $404.3M | $2.8M | ||
| Q3 25 | $402.6M | $4.1M | ||
| Q2 25 | — | $2.0M | ||
| Q1 25 | $263.2M | $3.5M | ||
| Q4 24 | $275.2M | $3.4M | ||
| Q3 24 | $281.1M | $5.0M | ||
| Q2 24 | $360.7M | $1.6M | ||
| Q1 24 | $377.0M | — |
| Q4 25 | — | $150.0K | ||
| Q3 25 | — | $150.0K | ||
| Q2 25 | — | $150.0K | ||
| Q1 25 | — | $150.0K | ||
| Q4 24 | — | $150.0K | ||
| Q3 24 | — | $150.0K | ||
| Q2 24 | — | $150.0K | ||
| Q1 24 | — | $150.0K |
| Q4 25 | $493.4M | $3.5M | ||
| Q3 25 | $546.5M | $4.4M | ||
| Q2 25 | — | $2.4M | ||
| Q1 25 | $328.6M | $4.1M | ||
| Q4 24 | $352.5M | $4.0M | ||
| Q3 24 | $337.9M | $6.0M | ||
| Q2 24 | $358.2M | $3.0M | ||
| Q1 24 | $372.7M | $7.2M |
| Q4 25 | $530.9M | $5.4M | ||
| Q3 25 | $577.4M | $6.7M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | $348.6M | $6.0M | ||
| Q4 24 | $374.0M | $5.8M | ||
| Q3 24 | $354.2M | $7.4M | ||
| Q2 24 | $369.0M | $4.3M | ||
| Q1 24 | $382.5M | $8.4M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-47.0M | $-1.7M |
| Free Cash FlowOCF − Capex | $-47.1M | $-1.8M |
| FCF MarginFCF / Revenue | -16591.9% | -584.2% |
| Capex IntensityCapex / Revenue | 48.6% | 26.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-132.8M | $-7.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-47.0M | $-1.7M | ||
| Q3 25 | $-30.6M | $-2.1M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-27.6M | $-1.6M | ||
| Q4 24 | $-27.4M | $-1.6M | ||
| Q3 24 | $-21.3M | $-1.7M | ||
| Q2 24 | $-14.5M | $-1.2M | ||
| Q1 24 | $-14.9M | $-1.1M |
| Q4 25 | $-47.1M | $-1.8M | ||
| Q3 25 | $-30.6M | $-2.1M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | $-27.7M | $-1.6M | ||
| Q4 24 | $-27.5M | — | ||
| Q3 24 | $-21.3M | $-1.7M | ||
| Q2 24 | $-14.5M | — | ||
| Q1 24 | $-15.0M | — |
| Q4 25 | -16591.9% | -584.2% | ||
| Q3 25 | -7717.2% | -484.2% | ||
| Q2 25 | — | -1483.6% | ||
| Q1 25 | -2377.8% | -978.3% | ||
| Q4 24 | -2072.0% | — | ||
| Q3 24 | -980.3% | -1252.8% | ||
| Q2 24 | -780.7% | — | ||
| Q1 24 | -1713.2% | — |
| Q4 25 | 48.6% | 26.3% | ||
| Q3 25 | 1.3% | 2.3% | ||
| Q2 25 | — | 46.9% | ||
| Q1 25 | 2.1% | 1.6% | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 1.2% | 10.2% | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 3.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -2.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
